Novel coronavirus infection in the third trimester of pregnancy: perinatal and maternal outcomes

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To investigate the characteristic features of the course of pregnancy, labor, and perinatal outcomes in women who had novel coronavirus disease 2019 (COVID-19) in the third trimester of pregnancy and gave birth after COVID-19.

Materials and methods: The study group included 313 patients divided into subgroups 1 (n=90), 2 (n=154), and 3 (n=69) who had COVID-19 at 28–32, 32.1–36.6 and ≥37 weeks of gestation, respectively. The comparison group included 216 women who gave birth before the COVID-19 pandemic (2019). Histological examination of the placenta was performed in the study (n=87) and comparison (n=20) groups.

Results: COVID-19 at 28–32 weeks increases the risk of fetal growth restriction (relative risk (RR)=5.6; 95% CI 2.4; 13.0; p<0.001), preterm birth (RR=2.7; 95% CI 1.2; 5.8; p=0.01), placental abruption (RR=5.2; 95% CI 1.6; 16.4; p=0.002), fetal distress (RR=4.9; 95% CI 1.7; 13.6; p=0.001), and emergency caesarean section (RR=4.0; 95% CI 1.8; 9.1; p=0.001). The newborns had significantly smaller chest circumferences and lower Apgar scores. The placentas showed marked signs of maternal and fetal vascular malperfusion. COVID-19 at 32.1–36.6 weeks gestation increased the risk of uteroplacental circulation disorders (UPCD) (RR=4.3; 95% CI 1.1; 16.1; p=0.02), preterm birth (RR=2.8; 95% CI 1.4; 5.6; p<0.001), fetal distress (RR=3.9; 95% CI 1.5; 10.3; p=0.003), and emergency caesarean section (RR=3.4; 95% CI 1.6; 7.3, p=0.001). Newborns had a significantly smaller chest circumference and lower Apgar scores. COVID-19 after 37 weeks increased the risk of UPCD (RR=8.0; 95% CI 2.0; 31.9, p=0.001). Vascular abnormalities were most pronounced in the placentas of patients in group 1.

Conclusion: COVID-19 in the early and middle third trimesters is associated with the most adverse perinatal outcomes.

Full Text

Restricted Access

About the authors

Galina B. Malgina

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: galinamalgina@mail.ru
ORCID iD: 0000-0002-5500-6296

Dr. Med. Sci., Director

Russian Federation, Yekaterinburg

Maria M. Dyakova

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Author for correspondence.
Email: mariadakova40@mail.ru
ORCID iD: 0000-0001-7911-6783

Junior Researcher

Russian Federation, Yekaterinburg

Svetlana V. Bychkova

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: simomm@mail.ru
ORCID iD: 0000-0002-8892-7585

PhD, Leading Researcher

Russian Federation, Yekaterinburg

Anastasia A. Grishkina

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: xumukyc.ru@mail.ru
ORCID iD: 0000-0001-7433-2217

PhD, Pathologist, Department of Immunology, Clinical Microbiology, Pathomorphology and Cytodiagnosis

Russian Federation, Yekaterinburg

Oksana A. Melkozerova

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: abolmed@mail.ru
ORCID iD: 0000-0002-4090-0578

Dr. Med. Sci., Deputy Director for Science

Russian Federation, Yekaterinburg

Nadezhda V. Bashmakova

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: bashmakovanv@niiomm.ru
ORCID iD: 0000-0001-5746-316X

Dr. Med. Sci., Professor, Chief Researcher

Russian Federation, Yekaterinburg

Natalia A. Pepelyaeva

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: pepelyaevana@niiomm.ru
ORCID iD: 0000-0003-3278-2249

PhD, Chief Physician

Russian Federation, Yekaterinburg

Sergey S. Olkov

Ural Research Institute of Maternity and Child Care, Ministry of Health of the Russian Federation

Email: olkovss@niiomm.ru
ORCID iD: 0000-0002-6142-3707

PhD, Deputy Head of the Pediatrics Clinic

Russian Federation, Yekaterinburg

References

  1. Radzinsky V.E., Milovanov A.P. Extraembryonic and amniotic structures in normal and complicated pregnancy. Moscow: MIA; 2004. 393p. (in Russian).
  2. Sidorova I.S., Makarov I.O. The course and management of pregnancy by trimester. Moscow: MIA; 2009. 304 p. (in Russian).
  3. Malgina G.B., Dyakova M.M., Bychkova S.V., Grishkina A.A., Pepelyaeva N.A., Olkov S.S., Melkozerova O.A., Bashmakova N.V., Davydenko N.B. Novel coronavirus infection in the first trimester of pregnancy: perinatal and maternal outcomes. Obstetrics and Gynecology. 2022; (12): 90-9. (in Russian). https://dx.doi.org/10.18565/aig.2022.212.
  4. la Cour Freiesleben N., Egerup P., Hviid K.V.R., Severinsen E.R., Kolte A.M., Westergaard D. et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum. Reprod. 2021; 36(1): 40-7. https://dx.doi.org/10.1093/humrep/deaa311.
  5. Baud D., Greub G., Favre G., Gengler C., Jaton K., Dubruc E., Pomar L. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2infection. JAMA. 2020; 23(21): 2198-200. https://dx.doi.org/10.1001/jama.2020.7233.
  6. Turgut E., Sakcak B., Uyan Hendem D., Oluklu D., Goncu Ayhan S., Sahin D. Decreased fetal cardiac output in pregnant women with severe SARS-Cov-2 infection. Echocardiography. 2022; 39(6): 803-10. https://dx.doi.org/10.1111/echo.15367.
  7. Zhang L., Dong L., Ming L., Wei M., Li J., Hu R., Yang J. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China. Pregnancy Childbirth. 2020; 20(1): 394. https://dx.doi.org/10.1186/s12884-020-03026-3.
  8. Piekos S.N., Roper R.T., Hwang Y.M., Sorensen T., Price N.D., Hood L., Hadlock J.J. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit. Health. 2022; 4(2): e95-e104. https://dx.doi.org/10.1016/S2589-7500(21)00250-8.
  9. Li N., Han L., Peng M., Lv Y., Ouyang Y., Liu K. et al. Maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (COVID-19) pneumonia: a case-control study. Clin. Infect. Dis. 2020; 71(16): 2035-41. https://dx.doi.org/10.1093/cid/ciaa352.
  10. Cosma S., Carosso A.R., Cusato J., Borella F., Carosso M., Gervasoni F. et al. Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. PLoS One. 2021; 16(8): e0254875. https://dx.doi.org/10.1371/journal.pone.0254875.
  11. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P.; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 2008; 61(4): 344-9. https://dx.doi.org/10.1016/ j.jclinepi.2007.11.008.
  12. Ministry of Health of the Russian Federation. Organization of medical care for pregnant women, women in labor, women in labor and newborns with a new coronavirus infection COVID-19. Methodological guidelines. Version 2, 28.05.2020. Version 3, 25.01.2021, Version 4, 05.07.2021 (in Russian).
  13. Statistical methods. Random sampling and randomization procedures. Standart ISO 24153-2012. Group T59. OKS 03.120.30. (in Russian).
  14. Sealed Envelope Ltd. 2012. Power calculator for binary outcome superiority trial. Available at: https://www.sealedenvelope.com/power/binary-superiority
  15. Khong T.Y., Mooney E.E., Gordijn S.J., Morgan T.K., Nikkels P.G.J. et al. Pathology of the placenta: Practical guide. Springer: Nature; 2019. https://dx.doi.org/10.1007/978-3-319-97214-5.
  16. Adamyan L.V., Vechorko V.I., Konysheva O.V., Kharchenko E.I. Pregnancy and COVID-19: current issues (literature review). Russian Journal of Human Reproduction. 2021; 27(3): 70-7. (in Russian). https://dx.doi.org/10.17116/repro20212703170.
  17. Eskenazi B., Rauch S., Iurlaro E., Gunier R.B., Rego A., Gravett M.G. et al. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study. Am. J. Obstet. Gynecol. 2022; 227(1): 74.e1-74. https://dx.doi.org/10.1016/ j.ajog.2021.12.032.
  18. Malgina G.B. Stress and pregnancy: perinatal aspects. Yekaterinburg; 2002. 188p. (in Russian).
  19. Gulkevich Yu.V., Makkaveeva M.Yu., Nikiforov B.I. Pathology of the human afterbirth and its effect on the fetus. Minsk; 1968. 232p. (in Russian).
  20. Yusenko S.R., Nagorneva S.V., Kogan I.Yu. Patterns of development and formation of the fetal central nervous system integrative function in the antenatal period. Journal of obstetrics and woman diseases. 2022; 71(5): 97-110. (in Russian). https:/dx./doi.org/10.17816/ JOWD107183.
  21. Hosier H., Farhadian S.F., Morotti R.A., Deshmukh U., Lu-Culligan A., Campbell K.H. et al. SARS-CoV-2 infection of the placenta. J. Clin. Invest. 2020; 130(9): 4947-53. https://dx.doi.org/10.1172/JCI139569.
  22. Wong S.F., Chow K.M., Leung T.N., Ng W.F., Ng T.K., Shek C.C. et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am. J. Obstet. Gynecol. 2004; 191(1): 292-7. https://dx.doi.org/10.1016/ j.ajog.2003.11.019.
  23. Jafari M., Pormohammad A., Neshin S.A.S., Ghorbani S., Bose D. et al. et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: Aasystematic review and meta-analysis. Rev. Med. Virol. 2021; 31(5): 1-16. https://dx.doi.org/10.1002/ rmv.2208.
  24. Martinez-Perez O., Prats Rodriguez P., Muner Hernandez M., Encinas Pardilla M.B., Perez Perez N., Vila Hernandez M.R. et al. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis. BMC Pregnancy Childbirth. 2021; 21(1): 273. https://dx.doi.org/10.1186/s12884-021-03742-4.
  25. Filippov O.S., Guseva E.V. Key performance indicators of the obstetric and gynecological service in the Russian Federation in 2019. Moscow; 2020. 30p. (in Russian).
  26. Vivanti A.J., Vauloup-Fellous C., Prevot S., Zupan V., Suffee C., Do Cao J. et al. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 2020; 11(1): 3572. https://dx.doi.org/10.1038/s41467-020-17436-6.
  27. Korebrits C., Ramirez M.M., Watson L., Brinkman E,. Bocking A.D., Challis J.R. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J. Clin. Endocrinol. Metab. 1998; 83(5): 1585-91. https://dx.doi.org/10.1210/jcem.83.5.4804.
  28. Shchegolev A.I., Tumanova U.N., Serov V.N. Placental lesions in pregnant women with SARS-¬CoV-¬2 infection. Obstetrics and Gynecology. 2020; (12: 44-52. (in Russian). https://dx.doi.org/10.18565/ aig.2020.12.44-52.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure. The structure of abdominal radiological resolution in patients of the compared groups, %

Download (56KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies